4lly
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A== | ==Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A== | ||
- | <StructureSection load='4lly' size='340' side='right' caption='[[4lly]], [[Resolution|resolution]] 1.60Å' scene=''> | + | <StructureSection load='4lly' size='340' side='right'caption='[[4lly]], [[Resolution|resolution]] 1.60Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4lly]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LLY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4LLY FirstGlance]. <br> | <table><tr><td colspan='2'>[[4lly]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LLY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4LLY FirstGlance]. <br> | ||
Line 22: | Line 22: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Atwell, S]] | [[Category: Atwell, S]] | ||
[[Category: Chamberlain, A K]] | [[Category: Chamberlain, A K]] |
Revision as of 07:13, 26 June 2019
Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A
|
Categories: Human | Large Structures | Atwell, S | Chamberlain, A K | Demarest, S J | Guntas, G | Hansen-Estruch, C | Ho, C | Huang, F | Kuhlman, B | Leaver-Fay, A | Lewis, S M | Pustilnik, A | Sereno, A | Smith, E M | Truhlar, S M | Wu, X | Fab | Immune system